Maplelane Capital’s Cavium, Inc. CAVM Stock Holding History

Maplelane Capital’s Portfolio CAVM Stock Details CAVM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-200,000	Closed	-$7.07M	–	234
2013 Q2	$7.07M	Buy	+200,000	New	+$6.68M	0.44%	58

Other funds holding CAVM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIM

abrdn Investment Management Edinburgh, United Kingdom $29.6B AUM 25.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Maplelane Capital's CAVM Position: Q1 2017 in Review

Maplelane Capital sold out of Cavium, Inc. (CAVM) in Q1 2017, closing a stake of 1 share.

Maplelane Capital first reported a position in CAVM in Q2 2013 and held it in 6 quarters. The position peaked at $15.8M in Q2 2016. 242 funds tracked by Wall St. Rank hold CAVM as of Q1 2017.

Maplelane Capital reported no remaining Cavium, Inc. position as of Q1 2017 after selling out during the quarter.
Maplelane Capital sold 1 Cavium, Inc. share in Q1 2017.
Maplelane Capital first reported a position in Cavium, Inc. in Q2 2013 and held it in 6 quarters.
Maplelane Capital's Cavium, Inc. position peaked at $15.8M in Q2 2016.
242 funds tracked by Wall St. Rank held Cavium, Inc. as of Q1 2017.

Based on Maplelane Capital's 13F filing for Q1 2017, filed 15 May 2017.